Drug Profile
Research programme: skin atrophy therapeutics - Topimed
Alternative Names: DIK 61Latest Information Update: 02 Oct 2015
Price :
$50
*
At a glance
- Originator Topimed
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Skin disorders
Most Recent Events
- 06 Jun 2005 Preclinical trials in Skin disorders in Israel (Topical)